Spectaire Holdings Inc. announced the upcoming release of AireCore 2.0, the next generation in micro mass spectrometry. Scheduled for shipment in First Quarter 2025, AireCore 2.0 will feature Double Focusing Mass Spectrometry (DFMS), a significant advancement over the previous Single Focusing Mass Spectrometry ("SFMS") technology, positioning the Company for new revenue streams and substantial market opportunities. Key Enhancements with DFMS: Enhanced Resolution and Accuracy: DFMS technology allows for greater separation of ions with similar mass-to-charge ratios, providing higher resolution and more accurate mass determinations.

Broader Analytical Range: DFMS expands the range of detectable molecules, including those with higher masses and more complex structures. These advancements will enable the identification of a wider array of substances, including complex organic and biological molecules. As a result, Aire Core 2.0 will open new markets for Spectaire, including pharmaceuticals, environmental analysis, agricultural monitoring, and advanced materials research, while continuing to enhance capabilities in the Company's core industries such as logistics and energy.

The enhanced capabilities of AireCore 2.0 significantly strengthen Spectaire?s ability to capitalize on this growth. The increased resolution and sensitivity will attract more customers seeking precise, reliable, and cost-effective solutions, ultimately driving significant revenue growth for Spectaire. Spectaire is poised to revolutionize the field of micro mass spectrometry with AireCore 2.0, setting a new standard for accuracy and accessibility.